Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Anti-human-CPR (C reactive protein) antibody and application thereof

An antibody and reactive protein technology, applied in the application, anti-animal/human immunoglobulin, biochemical equipment and methods, etc., can solve problems such as insufficient risk prediction, and achieve the effect of simple operation and convenient mass production

Active Publication Date: 2016-06-29
ZONHON BIOPHARMA INST
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CRP is usually measured by antibody turbidimetry or immunoturbidimetry, and their detection ability is above 3-5 mg / L. This level is only suitable for the prediction of infection, and the risk prediction for coronary artery and cerebrovascular is far from enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human-CPR (C reactive protein) antibody and application thereof
  • Anti-human-CPR (C reactive protein) antibody and application thereof
  • Anti-human-CPR (C reactive protein) antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1. Preparation of anti-human C-reactive protein hybridoma cell line

[0043] 1. Animal immunization

[0044] BALB / c female mice (purchased from Changzhou Cavens Experimental Animal Co., Ltd.) were immunized with C-reactive protein extracted from human plasma (purchased from HyTest Company) according to the general immunization procedure. For specific immunization conditions, please refer to the "Experimental Guidelines for Antibody Preparation and Use". The serum titer of immunized mice was tracked by indirect ELISA method, and the immunized mouse with the highest serum titer was selected for fusion experiment of mouse splenocytes and mouse myeloma cells.

[0045] 2. Cell Fusion

[0046] (1). Preparation of spleen cells

[0047] Take the immunized mice, remove their eyeballs, take blood, put them to death by breaking the cervical spine, soak them in 75% (v / v) alcohol for 10 minutes, take out their spleens in a sterile operating table, place them in a cell ...

Embodiment 2

[0057] Example 2. Determination of the variable region sequence of the hybridoma cell line antibody

[0058] The sequences of the antibody variable regions of the above-mentioned hybridoma cell lines M24 and M03 were determined.

[0059] a. Extraction of RNA: Extract the total RNA of the above-mentioned hybridoma cell lines M24 and M03 with reference to the instructions of the Total Cell RNA Extraction Kit (purchased from Roche Company) and perform reverse transcription immediately;

[0060] b. RNA reverse transcription into DNA: refer to ThermoScientificRevertedFirststrandcDNASynthesisKit (purchased from Thermo Company) to reverse-transcribe the total RNA extracted in the previous step to obtain cDNA, and freeze it at -20°C for later use;

[0061] c. PCR amplification and recovery of the variable region sequence: the cDNA obtained in the above step is used as a template, and the variable region sequence of the heavy chain and light chain is sequenced with the general primer f...

Embodiment 3

[0065] Example 3. Recombinant expression and purification of single-chain antibody

[0066] According to the sequencing results in Example 2, a linking peptide (GGGGS) was added between the heavy chain and light chain variable regions of the hybridoma cell lines M24 and M03 antibody respectively 3 , introduce six histidine tags SEQ ID NO: 17, and perform recombinant expression of single-chain antibodies by codon-optimizing the whole gene fusion histidine tags according to the preference of the Pichia pastoris expression system. The expressed antibodies were named as antibody P24 and antibody P03 respectively, and their structures and compositions are shown in the attached figure 2 shown. The recombinant expression of the above-mentioned single-chain antibody is specifically as follows:

[0067] a) Expression plasmid construction of fusion protein gene

[0068] The nucleotide sequence of the codon-optimized antibody P24 is shown in SEQ ID NO: 18, and the amino acid sequence...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to an anti-human-CPR (C reactive protein) antibody and an application thereof. Multiple antibodies are prepared and subjected to matched screening, and an antibody combination (P24 and P03) with sensitivity and specificity meeting the requirement is obtained; meanwhile, mass production of the antibody combination is facilitated, and the requirement of later large-scale clinical application can be met. The antibody combination is subjected to debugging optimization work by a detection system, a time-resolved immunofluorescence chromatography quantitative detection card for human CPR is obtained and is simple and convenient to operate, and the sensitivity, the specificity and related detection performance of the time-resolved immunofluorescence chromatography quantitative detection card can meet the requirement of human clinical sample detection.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to two anti-human C-reactive protein (CRP) antibodies, a preparation method thereof and the application of the antibodies in the detection of human C-reactive protein. Background technique [0002] C-reactive protein (Creactive protein, CRP) is a member of the protein family. It is an acute phase response protein. The plasma concentration rises sharply during tissue damage and bacterial infection. It is an important defense molecule of the body, mainly produced by the liver and secretion. CRP is composed of five identical spherical monomers combined by non-covalent bonds to form a stable disc structure, which belongs to the regular pentamer family. CRP is a symmetrical pentahedron in structure, its monomer is composed of 206 amino acids, its molecular weight is about 23KDa, and the total molecular weight of CRP is about 118KDa. CRP participates in various inflammatory and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/18C12N15/13G01N33/68
CPCC07K16/18C07K2317/565
Inventor 马永赵利利杨芸王安良范宇
Owner ZONHON BIOPHARMA INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com